Page last updated: 2024-11-05

thiotepa and Leukoma

thiotepa has been researched along with Leukoma in 3 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson Penno, E1
Braun, DA1
Kamal, A1
Hamilton, WK1
Gimbel, HV1
LAVERGNE, G2
COLMANT, IA2

Other Studies

3 other studies available for thiotepa and Leukoma

ArticleYear
Topical thiotepa treatment for recurrent corneal haze after photorefractive keratectomy.
    Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:8

    Topics: Administration, Topical; Adult; Antineoplastic Agents, Alkylating; Astigmatism; Corneal Opacity; Hum

2003
[INHIBITION OF CORNEAL VASCULARIZATION BY TRIETHYLENETHIO-PHOSPHORAMIDE. EXPERIMENTAL AND CLINICAL STUDY].
    Bulletin de la Societe belge d'ophtalmologie, 1963, Volume: 135

    Topics: Blood Vessels; Corneal Opacity; Corneal Ulcer; Keratitis; Pharmacology; Phosphoramides; Rabbits; Res

1963
COMPARATIVE STUDY OF THE ACTION OF THIOTEPA AND TRIAMCINOLONE ON CORNEAL VASCULARIZATION IN RABBITS.
    The British journal of ophthalmology, 1964, Volume: 48

    Topics: Animals; Blood Vessels; Cautery; Cell Division; Cornea; Corneal Neovascularization; Corneal Opacity;

1964